Activity in this selectionmetaplanet-87503ea4
- Rounds participated in
- 1
- Confirmed lead rounds
- —
1 roles undisclosed- New companies
- 1
First participation on record · 0 follow-on- Funding in participating rounds
- $13M
1 disclosed · full round size, not this investor’s share
Rounds
1 in this selectionParcelBioDevelops potent and durable mRNA medicines using the APEXm platform for autoimmune and oncology
Role not disclosed